Education
About Us
Working with TipRanks
Follow Us
Virpax Pharmaceuticals (VRPX)
OTHER OTC:VRPX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -12.08B | $ -15.69M | $ -21.85M | $ -12.03M | $ -4.20M |
| EBITDA | $ -12.08B | $ -14.69M | $ 0.00 | $ 0.00 | $ 4.00K |
| Net Income | $ -12.07B | $ -15.19M | $ -21.46M | $ -12.15M | $ -4.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.51B | $ 9.14M | $ 19.00M | $ 36.84M | $ 54.80K |
| Total Assets | $ 1.56B | $ 9.63M | $ 19.67M | $ 39.57M | $ 465.41K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.57M |
| Net Debt | $ -1.51M | $ -9.14M | $ -19.00M | $ -36.84M | $ 1.51M |
| Total Liabilities | $ 2.47B | $ 7.69M | $ 3.09M | $ 2.09M | $ 4.68M |
| Stockholders' Equity | $ -913.76M | $ 1.93M | $ 16.58M | $ 37.48M | $ -4.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.71B | $ -9.85M | $ -17.85M | $ -14.54M | $ -1.38M |
| Operating Cash Flow | $ -16.71B | $ -9.85M | $ -17.85M | $ -14.54M | $ -1.38M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 9.08B | $ 0.00 | $ 0.00 | $ 51.33M | $ 1.40M |
Virpax Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.